TP53 and Haim-Munk syndrome: The high frequency of TP53 and RAS mutations in MGCTs with concomitant HMs, and the presence of these alterations in the common precursor clone, leads researcher to suppose that TP53/RAS pathway alterations are necessary for PGCs to survive in the extragonadal niche [69,79].